Skip to main content
Erschienen in: Brain Tumor Pathology 1/2021

24.10.2020 | Case Report

Genetic characterization of an aggressive optic nerve pilocytic glioma

verfasst von: Christopher S. Hong, Greg Fliney, Adeniyi Fisayo, Yi An, Pallavi P. Gopal, Antonio Omuro, Renelle Pointdujour-Lim, E. Zeynep Erson-Omay, S. Bulent Omay

Erschienen in: Brain Tumor Pathology | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Optic nerve glioma (ONG) is a rare, typically slow-growing WHO I grade tumor that affects the visual pathways. ONG is most commonly seen in the pediatric population, in association with neurofibromatosis type 1 syndrome. However, sporadic adult cases may also occur and may clinically behave more aggressively, despite benign histopathology. Genetic characterization of these tumors, particularly in the adult population, is lacking. A 39-year-old female presented with 1 month of progressive left-sided visual loss secondary to a enhancing mass along the left optic nerve sheath. Initial empiric management with focal radiotherapy failed to prevent tumor progression, prompting open biopsy which revealed a WHO I pilocytic astrocytoma of the optic nerve. Whole-exome sequencing of the biopsy specimen revealed somatic mutations in NF1,FGFR1 and PTPN11 that may provide actionable targets for molecularly guided therapies. Genetic characterization of ONG is lacking but is needed to guide the management of these rare but complex tumors. The genomic alterations reported in this case contributes to understanding the pathophysiology of adult sporadic ONG and may help guide future clinical prognostication and development of targeted therapies.
Literatur
1.
Zurück zum Zitat Shapey J, Danesh-Meyer HV, Kaye AH (2011) Diagnosis and management of optic nerve glioma. J Clin Neurosci 18(12):1585–1591CrossRef Shapey J, Danesh-Meyer HV, Kaye AH (2011) Diagnosis and management of optic nerve glioma. J Clin Neurosci 18(12):1585–1591CrossRef
2.
Zurück zum Zitat Pasol J, Sternau L, Luetmer P, Giannini C (2010) Rapid progressive unilateral visual loss in an elderly man. J Neuroophthalmol 30(2):188–192CrossRef Pasol J, Sternau L, Luetmer P, Giannini C (2010) Rapid progressive unilateral visual loss in an elderly man. J Neuroophthalmol 30(2):188–192CrossRef
3.
Zurück zum Zitat Bilgin G, Al-Obailan M, Bonelli L, Glasgow BJ, Vinters HV, Arnold AC (2014) Aggressive low-grade optic nerve glioma in adults. Neuroophthalmology 38(6):297–309CrossRef Bilgin G, Al-Obailan M, Bonelli L, Glasgow BJ, Vinters HV, Arnold AC (2014) Aggressive low-grade optic nerve glioma in adults. Neuroophthalmology 38(6):297–309CrossRef
4.
Zurück zum Zitat Farazdaghi MK, Katowitz WR, Avery RA (2019) Current treatment of optic nerve gliomas. Curr Opin Ophthalmol 30(5):356–363CrossRef Farazdaghi MK, Katowitz WR, Avery RA (2019) Current treatment of optic nerve gliomas. Curr Opin Ophthalmol 30(5):356–363CrossRef
5.
Zurück zum Zitat Bale TA (2020) FGFR- gene family alterations in low-grade neuroepithelial tumors. Acta Neuropathol Commun 8(1):21CrossRef Bale TA (2020) FGFR- gene family alterations in low-grade neuroepithelial tumors. Acta Neuropathol Commun 8(1):21CrossRef
6.
Zurück zum Zitat Liu KW, Feng H, Bachoo R et al (2011) SHP-2/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A/ARF aberrations in mice and humans. J Clin Invest 121(3):905–917CrossRef Liu KW, Feng H, Bachoo R et al (2011) SHP-2/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A/ARF aberrations in mice and humans. J Clin Invest 121(3):905–917CrossRef
7.
Zurück zum Zitat Kundishora AJ, Reeves BC, Nelson-Williams C et al (2020) Novel EWSR1-VGLL1 fusion in a pediatric neuroepithelial neoplasm. Clin Genet 97(5):791–792CrossRef Kundishora AJ, Reeves BC, Nelson-Williams C et al (2020) Novel EWSR1-VGLL1 fusion in a pediatric neuroepithelial neoplasm. Clin Genet 97(5):791–792CrossRef
8.
Zurück zum Zitat Dutton JJ (1994) Gliomas of the anterior visual pathway. Surv Ophthalmol 38(5):427–452CrossRef Dutton JJ (1994) Gliomas of the anterior visual pathway. Surv Ophthalmol 38(5):427–452CrossRef
9.
Zurück zum Zitat Campbell AA, Gartrell-Corrado RD, Mansukhani M et al (2019) SETD2 mutation in an aggressive optic nerve glioma. JAMA Ophthalmol 2:6–10 Campbell AA, Gartrell-Corrado RD, Mansukhani M et al (2019) SETD2 mutation in an aggressive optic nerve glioma. JAMA Ophthalmol 2:6–10
10.
Zurück zum Zitat Verhaak RG, Hoadley KA, Purdom E et al (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17(1):98–110CrossRef Verhaak RG, Hoadley KA, Purdom E et al (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17(1):98–110CrossRef
11.
Zurück zum Zitat Gutmann DH, Loehr A, Zhang Y, Kim J, Henkemeyer M, Cashen A (1999) Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation. Oncogene 18(31):4450–4459CrossRef Gutmann DH, Loehr A, Zhang Y, Kim J, Henkemeyer M, Cashen A (1999) Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation. Oncogene 18(31):4450–4459CrossRef
12.
Zurück zum Zitat Ding H, Shannon P, Lau N et al (2003) Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model. Cancer Res 63(5):1106–1113PubMed Ding H, Shannon P, Lau N et al (2003) Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model. Cancer Res 63(5):1106–1113PubMed
13.
Zurück zum Zitat Philpott C, Tovell H, Frayling IM, Cooper DN, Upadhyaya M (2017) The NF1 somatic mutational landscape in sporadic human cancers. Hum Genomics 11(1):13CrossRef Philpott C, Tovell H, Frayling IM, Cooper DN, Upadhyaya M (2017) The NF1 somatic mutational landscape in sporadic human cancers. Hum Genomics 11(1):13CrossRef
14.
Zurück zum Zitat Trisolini E, Wardighi DE, Giry M et al (2019) Actionable FGFR1 and BRAF mutations in adult circumscribed gliomas. J Neurooncol 145(2):241–245CrossRef Trisolini E, Wardighi DE, Giry M et al (2019) Actionable FGFR1 and BRAF mutations in adult circumscribed gliomas. J Neurooncol 145(2):241–245CrossRef
15.
Zurück zum Zitat Wang J, Cazzato E, Ladewig E et al (2016) Clonal evolution of glioblastoma under therapy. Nat Genet 48(7):768–776CrossRef Wang J, Cazzato E, Ladewig E et al (2016) Clonal evolution of glioblastoma under therapy. Nat Genet 48(7):768–776CrossRef
16.
Zurück zum Zitat Nair S, Fort JA, Yachnis AT, Williams CA (2015) Optic nerve pilomyxoid astrocytoma in a patient with Noonan syndrome. Pediatr Blood Cancer 62(6):1084–1086CrossRef Nair S, Fort JA, Yachnis AT, Williams CA (2015) Optic nerve pilomyxoid astrocytoma in a patient with Noonan syndrome. Pediatr Blood Cancer 62(6):1084–1086CrossRef
17.
Zurück zum Zitat Tartaglia M, Martinelli S, Stella L et al (2006) Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease. Am J Hum Genet 78(2):279–290CrossRef Tartaglia M, Martinelli S, Stella L et al (2006) Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease. Am J Hum Genet 78(2):279–290CrossRef
18.
Zurück zum Zitat Liu WS, Yang B, Wang RR et al (2020) Design, synthesis and biological evaluation of pyridine derivatives as selective SHP2 inhibitors. Bioorg Chem 100:103875CrossRef Liu WS, Yang B, Wang RR et al (2020) Design, synthesis and biological evaluation of pyridine derivatives as selective SHP2 inhibitors. Bioorg Chem 100:103875CrossRef
19.
Zurück zum Zitat Chen YN, LaMarche MJ, Chan HM et al (2016) Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases. Nature 535(7610):148–152CrossRef Chen YN, LaMarche MJ, Chan HM et al (2016) Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases. Nature 535(7610):148–152CrossRef
20.
Zurück zum Zitat Packer RJ, Ater J, Allen J et al (1997) Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 86(5):747–754CrossRef Packer RJ, Ater J, Allen J et al (1997) Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 86(5):747–754CrossRef
21.
Zurück zum Zitat Massimino M, Spreafico F, Cefalo G et al (2002) High response rate to cisplatin/etoposide regimen in childhood low-grade glioma. J Clin Oncol 20(20):4209–4216CrossRef Massimino M, Spreafico F, Cefalo G et al (2002) High response rate to cisplatin/etoposide regimen in childhood low-grade glioma. J Clin Oncol 20(20):4209–4216CrossRef
22.
Zurück zum Zitat Gururangan S, Fisher MJ, Allen JC et al (2007) Temozolomide in children with progressive low-grade glioma. Neuro Oncol 9(2):161–168CrossRef Gururangan S, Fisher MJ, Allen JC et al (2007) Temozolomide in children with progressive low-grade glioma. Neuro Oncol 9(2):161–168CrossRef
23.
Zurück zum Zitat Hidalgo ET, Kvint S, Orillac C et al (2019) Long-term clinical and visual outcomes after surgical resection of pediatric pilocytic/pilomyxoid optic pathway gliomas. J Neurosurg Pediatr 13:1–8 Hidalgo ET, Kvint S, Orillac C et al (2019) Long-term clinical and visual outcomes after surgical resection of pediatric pilocytic/pilomyxoid optic pathway gliomas. J Neurosurg Pediatr 13:1–8
24.
Zurück zum Zitat Taveras JM, Mount LA, Wood EH (1956) The value of radiation therapy in the management of glioma of the optic nerves and chiasm. Radiology 66(4):518–528CrossRef Taveras JM, Mount LA, Wood EH (1956) The value of radiation therapy in the management of glioma of the optic nerves and chiasm. Radiology 66(4):518–528CrossRef
25.
Zurück zum Zitat Montgomery AB, Griffin T, Parker RG, Gerdes AJ (1977) Optic nerve glioma: the role of radiation therapy. Cancer 40(5):2079–2080CrossRef Montgomery AB, Griffin T, Parker RG, Gerdes AJ (1977) Optic nerve glioma: the role of radiation therapy. Cancer 40(5):2079–2080CrossRef
26.
Zurück zum Zitat El-Shehaby AM, Reda WA, Abdel Karim KM, Emad Eldin RM, Nabeel AM (2016) Single-session Gamma Knife radiosurgery for optic pathway/hypothalamic gliomas. J Neurosurg 125(Suppl 1):50–57CrossRef El-Shehaby AM, Reda WA, Abdel Karim KM, Emad Eldin RM, Nabeel AM (2016) Single-session Gamma Knife radiosurgery for optic pathway/hypothalamic gliomas. J Neurosurg 125(Suppl 1):50–57CrossRef
Metadaten
Titel
Genetic characterization of an aggressive optic nerve pilocytic glioma
verfasst von
Christopher S. Hong
Greg Fliney
Adeniyi Fisayo
Yi An
Pallavi P. Gopal
Antonio Omuro
Renelle Pointdujour-Lim
E. Zeynep Erson-Omay
S. Bulent Omay
Publikationsdatum
24.10.2020
Verlag
Springer Singapore
Erschienen in
Brain Tumor Pathology / Ausgabe 1/2021
Print ISSN: 1433-7398
Elektronische ISSN: 1861-387X
DOI
https://doi.org/10.1007/s10014-020-00383-x

Weitere Artikel der Ausgabe 1/2021

Brain Tumor Pathology 1/2021 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.